Factors associated with the contraindicated use of oral contraceptives in brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | http://hdl.handle.net/1843/64099 |
Resumo: | OBJECTIVE: To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS: 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS: In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS: Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives |
id |
UFMG_71b407a163ce4fd9c5cabd87e3fc339c |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/64099 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
Factors associated with the contraindicated use of oral contraceptives in brazilContraceptives, Oral, CombinedPrescription Drug MisuseRisk Factors.Women’s HealthReproductive Health ServicesContraceptives, Oral, CombinedPrescription Drug MisuseRisk FactorsWomen’s HealthReproductive Health ServicesOBJECTIVE: To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS: 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS: In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS: Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptivesUniversidade Federal de Minas GeraisBrasilENF - DEPARTAMENTO DE ENFERMAGEM MATERNO INFANTIL E SAÚDE PÚBLICAUFMG2024-02-16T20:02:04Z2024-02-16T20:02:04Z2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlepdfapplication/pdf10.1590/s1518-8787.201705100611315188787http://hdl.handle.net/1843/64099engRevista de Saúde PúblicaDaniele Aparecida Silva CorreiaMariana Santos Felisbino MendesMayara Santos MendesGustavo Velasquez-melendezinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2024-02-16T20:05:03Zoai:repositorio.ufmg.br:1843/64099Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2024-02-16T20:05:03Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.none.fl_str_mv |
Factors associated with the contraindicated use of oral contraceptives in brazil |
title |
Factors associated with the contraindicated use of oral contraceptives in brazil |
spellingShingle |
Factors associated with the contraindicated use of oral contraceptives in brazil Daniele Aparecida Silva Correia Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors. Women’s Health Reproductive Health Services Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors Women’s Health Reproductive Health Services |
title_short |
Factors associated with the contraindicated use of oral contraceptives in brazil |
title_full |
Factors associated with the contraindicated use of oral contraceptives in brazil |
title_fullStr |
Factors associated with the contraindicated use of oral contraceptives in brazil |
title_full_unstemmed |
Factors associated with the contraindicated use of oral contraceptives in brazil |
title_sort |
Factors associated with the contraindicated use of oral contraceptives in brazil |
author |
Daniele Aparecida Silva Correia |
author_facet |
Daniele Aparecida Silva Correia Mariana Santos Felisbino Mendes Mayara Santos Mendes Gustavo Velasquez-melendez |
author_role |
author |
author2 |
Mariana Santos Felisbino Mendes Mayara Santos Mendes Gustavo Velasquez-melendez |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Daniele Aparecida Silva Correia Mariana Santos Felisbino Mendes Mayara Santos Mendes Gustavo Velasquez-melendez |
dc.subject.por.fl_str_mv |
Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors. Women’s Health Reproductive Health Services Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors Women’s Health Reproductive Health Services |
topic |
Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors. Women’s Health Reproductive Health Services Contraceptives, Oral, Combined Prescription Drug Misuse Risk Factors Women’s Health Reproductive Health Services |
description |
OBJECTIVE: To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS: 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS: In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS: Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 2024-02-16T20:02:04Z 2024-02-16T20:02:04Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
10.1590/s1518-8787.2017051006113 15188787 http://hdl.handle.net/1843/64099 |
identifier_str_mv |
10.1590/s1518-8787.2017051006113 15188787 |
url |
http://hdl.handle.net/1843/64099 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Revista de Saúde Pública |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
pdf application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais Brasil ENF - DEPARTAMENTO DE ENFERMAGEM MATERNO INFANTIL E SAÚDE PÚBLICA UFMG |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais Brasil ENF - DEPARTAMENTO DE ENFERMAGEM MATERNO INFANTIL E SAÚDE PÚBLICA UFMG |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
repositorio@ufmg.br |
_version_ |
1823248074153132032 |